Upperton Pharma : CDMO : Oral, Nasal and Pulmonary Dosage Forms
Your integrated CDMO partner of choice for oral, nasal and pulmonary dosage forms.
Meet with Ian Lafferty, Chief Technical Officer, to discover more.
As a leading Contract, Development and Manufacturing Organisation (CDMO) our defining traits lie in our adaptability and nimbleness.
Through our science-led approach we align to your drug development needs from pre-clinical to late phase manufacture, across oral solid dosage forms, liquids, semi-solids, nasal and inhaled products.
Our team support you at each stage of your drug program lifecycle from pre-clinical to market, with science-led expertise and unparalleled project delivery.
Our CDMO services include formulation development, phase 1, phase 2 and phase 3 clinical supply, process scale-up and optimisation, quality control, analytical development and validation, and registration activities.
Category:
CMC: Biologics, Drug Product CMC: Biologics, Analytical CMC: Biologics, Drug Delivery CMC: Small Molecules, Drug Product CMC: Small Molecules, Analytical CMC: Small Molecules, Drug Delivery